Target intelligence / Profile preview

Long intergenic non-protein coding RNA 658 (LINC00658)

Target
LINC00658
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 658 (LINC00658) is a long non-coding RNA found on human chromosome 20[5][1][7]. It is part of a broad family of lncRNAs that regulate gene expression through diverse mechanisms, including chromatin remodeling, and is implicated in cancer according to general lncRNA research[13][8]. LINC00658 itself has not been fully characterized as a direct therapeutic target, receptor, transporter, or enzyme, and does not have documented drug interactions. While lncRNAs, including LINC00658, show promise as cancer biomarkers and modulators of tumor progression, specific roles and clinical applications for LINC00658 remain to be defined.

Other names
LINC00658ENSG00000226995
02

Mechanism of action

lncRNAs can modulate gene expression by scaffolding chromatin-modifying complexes. lncRNAs may act as decoys, guides, or scaffolds for proteins/RNAs (general for this class). Involvement through epigenetic regulation and control of transcription.

03

Biological functions

Regulation of gene expression at transcriptional, post-transcriptional, translational, and post-translational levelsPossible involvement in chromatin modification and gene silencing (general property of lincRNAs)
04

Disease associations

Cancer (based on lincRNA family implications in cancer progression and metastasis)
05

Safety considerations

Therapeutic challenges are typical for lncRNA-targeted interventions, such as specificity and delivery

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 658 (LINC00658).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 658 (LINC00658).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call